Skip to main content
Clinical Trials/CTRI/2018/04/013204
CTRI/2018/04/013204
Not yet recruiting
未知

Evaluation of the efficacy of Shushkakshipaka-har anjana in Shushkakshipaka w.s.r.to Dry eye syndrome.

Campus Director0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Campus Director
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Campus Director

Eligibility Criteria

Inclusion Criteria

  • Patient having Shushkakshipaka (DES) symptoms â?? feeling of dryness, irritation, foreign body sensation, non specific ocular discomfort and chronically sore eyes, not responding to a variety of drops instilled earlier.
  • Defective blinking such as low blink rate as seen in prolonged computer and mobile phones users.
  • Vitamin A deficiency and other factors affecting ocular surface for example tropical drugs, preservative of contact lens bearers. Ocular surface allergic disease and scarring disorders.
  • Patient ready to give written consent and study till completion only will be selected.

Exclusion Criteria

  • Allergic by patient report.
  • Pregnancy or lactating mother.
  • Acute allergic conjunctivitis, infection (bacterial, viral, protozoan or fungal infection of cornea, conjunctiva, lacrimal gland, lacrimal sac or eye lids)
  • Inflammation (retinitis, macular inflammation, choroiditis, uveitis, scleritis, episcleritis and keratitis).
  • History of patient report of ocular herpetic keratitis.
  • Ocular surgery (including cataract surgery) by patient report within six months.
  • Previous LASIK surgery or any other corneal surgery.
  • Use of glaucoma medication or history of filtering surgery for glaucoma.
  • Extensive ocular surface scarring or condition that may compromise ocular surface integrity such as Stevens Johnson syndrome, prior chemical burn, recurrent corneal erosions, persistent corneal epithelial defects prior ocular trauma etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials